Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.

MLA

Matsui, Jennifer K., et al. “Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.” Biomedicines, vol. 10, no. 9, Sept. 2022. EBSCOhost, https://doi.org/10.3390/biomedicines10092211.

APA

Matsui, J. K., Perlow, H. K., Raj, R. K., Nalin, A. P., Lehrer, E. J., Kotecha, R., Trifiletti, D. M., McClelland, S., 3rd, Kendra, K., Williams, N., Owen, D. H., Presley, C. J., Thomas, E. M., Beyer, S. J., Blakaj, D. M., Ahluwalia, M. S., Raval, R. R., & Palmer, J. D. (2022). Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors. Biomedicines, 10(9). https://doi.org/10.3390/biomedicines10092211

Chicago

Matsui, Jennifer K, Haley K Perlow, Rohit K Raj, Ansel P Nalin, Eric J Lehrer, Rupesh Kotecha, Daniel M Trifiletti, et al. 2022. “Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.” Biomedicines 10 (9). doi:10.3390/biomedicines10092211.